Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EIF1P5 is classified as a pseudogene related to eukaryotic translation initiation factor 1 (EIF1), a protein that plays a critical role in start codon recognition during translation initiation. Pseudogenes are DNA sequences similar to known genes but typically lack the ability to encode functional proteins due to mutations or sequence truncations[2]. Unlike its parent gene, EIF1, which is involved in protein synthesis and has been studied for its roles in cancer biology[1], EIF1P5 does not produce an active protein and is not considered a target for drugs or therapies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 1 pseudogene 5 (EIF1P5).